Showing results (161-170 of 283) with videos related to

Sort By:
Pageof 29
Applied Biochemistry and Biotechnology|June 13, 2000
Effect of shear on human insulin in zinc suspensionR J Grainger, S Ko, E Koslov, et al.
RNA (New York, N.Y.)|October 27, 2009
Physical and genetic interactions of yeast Cwc21p, an ortholog of human SRm300/SRRM2, suggest a role at the catalytic center of the spliceosomeRichard J Grainger, J David Barrass, Alain Jacquier, et al.
Circulation|May 5, 1999
Monocyte chemoattractant protein-1 but not tumor necrosis factor-alpha is correlated with monocyte infiltration in mouse lipid lesionsJ Reckless, E M Rubin, J B Verstuyft, et al.
European Radiology|November 10, 2001
Fully automated software to monitor wear in prosthetic knees using fluoroscopic imagesJ Duryea, A J Grainger, I G Hide, et al.
The European Respiratory Journal|July 10, 1998
Lung abscess complicating chondromas in Carney's syndromeR P Convery, A J Grainger, N K Bhatnagar, et al.
Thorax|February 1, 1991
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control studyJ Grainger, K Woodman, N Pearce, et al.
The Biochemical Journal|April 1, 1994
Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phaseD J Grainger, P R Kemp, C M Witchell, et al.
British Journal of Sports Medicine|March 8, 2014
Do MRI and ultrasound of the anterior pelvis correlate with, or predict, young football players' clinical findings? A 4-year prospective study of elite academy soccer playersPhilip Robinson, Andrew J Grainger, Elizabeth M A Hensor, et al.
Cardiovascular Research|December 1, 1993
Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serumD J Grainger, C M Witchell, J V Watson, et al.
Journal of Medicinal Chemistry|February 4, 2005
Identification of 3-(acylamino)azepan-2-ones as stable broad-spectrum chemokine inhibitors resistant to metabolism in vivoDavid J Fox, Jill Reckless, Sibylle M Wilbert, et al.
Pageof 29